Other weight-loss drugs are currently in development or regulatory approval stages, including: Once-daily GLP-1 pill orforglipron (Eli Lilly), which, when taken alongside a healthy diet and exercise, resulted in a 7.5% weight loss over 72 weeks on the 6mg dose, 8.4% loss with 12mg of orforglipron, and 11.2% loss with 36mg of orforglipron, as compared with 2.1% loss with placebo (funded by Eli Lilly
Consistency is key: administering the injection on the same day and time each week will optimise your results
Key Takeaways Tirzepatide hair loss is usually temporary and linked to significant weight loss, metabolic stress, or nutritional deficiencies, not direct follicle damage
By doing so, it helps people feel fuller for longer, which can lead to reduced calorie intake and promote weight loss
Inverted nipples
Slows Gastric Emptying Tirzepatide mimics hormone interactions and thus, slows down the way your food moves through the stomach